A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times daily for 3 weeks. During a follow-up visit the client reports new symptoms. Which finding is most concerning and warrants immediate provider notification?

Lithium has a narrow therapeutic index (0.6 to 1.2 mEq/L). Coarse tremor, dysarthria (slurred speech), and ataxia indicate moderate to severe toxicity (level above 1.5 mEq/L) and require immediate hold, lithium level draw, and provider notification. Polyuria and polydipsia, fine tremor on awakening, and mild weight gain are common expected side effects at therapeutic levels.

In-depth explanation

<span class="merci-scenario-label">Clinical Judgment</span><br>Lithium toxicity is staged: <span class="merci-value">mild 1.5-2.0</span> (coarse tremor, GI), <span class="merci-value-abnormal">moderate 2.0-2.5</span> (ataxia, dysarthria, confusion), <span class="merci-value-abnormal">severe &gt;2.5</span> (seizure, coma). Ataxia + dysarthria + coarse tremor = <span class="merci-kw">moderate or worse toxicity</span>.<br><br><span class="merci-scenario-label">Memory Tip</span><br><span class="merci-kw-mark">Lithium toxicity ABCD: Ataxia, Blurred speech, Coarse tremor, Diarrhea</span><br><br><span class="merci-scenario-label">KR vs US</span><br>Therapeutic range and toxicity thresholds match worldwide. Korean psychiatric outpatients also draw quarterly lithium levels and check renal/thyroid function every 6 months.

Clinical scenario

<span class="merci-scenario-label">Clinical Practice Guide</span><br>APA bipolar disorder guidelines list lithium as first-line for maintenance and acute mania. Therapeutic range: <span class="merci-value">0.6-1.2 mEq/L</span> (acute mania up to 1.5). Toxicity stages: <span class="merci-value">mild 1.5-2.0</span> (coarse tremor, GI), <span class="merci-value-abnormal">moderate 2.0-2.5</span> (ataxia, dysarthria, confusion), <span class="merci-value-abnormal">severe &gt;2.5</span> (seizure, coma, death). Hemodialysis indicated if level &gt;4 or symptomatic at &gt;2.5.<br><br><span class="merci-scenario-label">Caution</span><br>Dehydration, low sodium intake, NSAIDs, ACE inhibitors, and thiazide diuretics raise lithium levels. <span class="merci-value-abnormal">Counsel clients to maintain consistent fluid and salt intake</span> and to avoid OTC NSAIDs without consultation.

Key concepts

• Lithium carbonate — First-line mood stabilizer for bipolar disorder. Narrow therapeutic index 0.6-1.2 mEq/L. Excreted unchanged by kidneys; renal function and serum levels checked every 3-6 months. Held before procedures with anticipated dehydration.
• Lithium toxicity — Mild (1.5-2.0): coarse tremor, GI distress, polyuria. Moderate (2.0-2.5): ataxia, slurred speech, confusion, muscle twitching. Severe (>2.5): seizure, coma, cardiovascular collapse. Hemodialysis for severe toxicity.
• Narrow therapeutic index — Drugs where toxic dose is close to therapeutic dose. Examples: lithium, warfarin, digoxin, theophylline, phenytoin, vancomycin. Require routine serum level monitoring and patient education on symptom recognition.